ClinVar Miner

Submissions for variant NM_000314.7(PTEN):c.422A>C (p.His141Pro) (rs863224666)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000197810 SCV000254527 pathogenic PTEN hamartoma tumor syndrome 2019-01-03 criteria provided, single submitter clinical testing This sequence change replaces histidine with proline at codon 141 of the PTEN protein (p.His141Pro). The histidine residue is highly conserved and there is a moderate physicochemical difference between histidine and proline. This variant is not present in population databases (ExAC no frequency). This variant has been observed in individuals with clinical features of PTEN-related disease, and shown to segregate with disease in two family members (Invitae). ClinVar contains an entry for this variant (Variation ID: 216422). This variant has been reported to affect PTEN protein function (PMID: 29706350, 29785012). This variant disrupts the p.His141 amino acid residue in PTEN. Other variant(s) that disrupt this residue have been observed in affected individuals (PMID: 25669429, Invitae), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV000218521 SCV000275105 uncertain significance Hereditary cancer-predisposing syndrome 2015-04-14 criteria provided, single submitter clinical testing Insufficient or conflicting evidence

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.